Episode 119 - Semaglutide for MASH
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Episode 119 - Semaglutide for MASH
-
Narrated by:
-
By:
About this listen
Send us a text
Welcome back, Rounds Table Listeners! This week we have a solo episode with Dr. John Fralick, discussing a recently published trial of the GLP-1 receptor agonist semaglutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Here we go!
- Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis (0:00 – 6:33).
The Good Stuff:
- Go Leafs go!
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
No reviews yet